Cargando…

Correlation between PPAR-α methylation level in peripheral blood and inflammatory factors of NAFLD patients with DM

The correlation between the methylation levels of peroxisome proliferator-activated receptor-α (PPAR-α) in the peripheral blood and the inflammatory factors associated with non-alcoholic fatty liver disease (NAFLD) patients with diabetes mellitus (DM) was investigated. Thirty-two samples of normal l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ju, Jianghua, Huang, Qingxian, Sun, Jing, Jin, Yongcheng, Ma, Wenjie, Song, Xiaohui, Sun, Huibo, Wang, Wenhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774500/ https://www.ncbi.nlm.nih.gov/pubmed/29434731 http://dx.doi.org/10.3892/etm.2017.5530

Ejemplares similares

Correlation between PPAR-α methylation level in peripheral blood and atherosclerosis of NAFLD patients with DM
por: Ju, Jianghua, et al.
Publicado: (2018)

Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity
por: Régnier, Marion, et al.
Publicado: (2020)

PPARα in the Epigenetic Driver Seat of NAFLD: New Therapeutic Opportunities for Epigenetic Drugs?
por: Theys, Claudia, et al.
Publicado: (2022)

PPARs and Mitochondrial Metabolism: From NAFLD to HCC
por: Mello, Tommaso, et al.
Publicado: (2016)

Insights into the Role of PPARβ/δ in NAFLD
por: Chen, Jiapeng, et al.
Publicado: (2018)

Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
por: Montagner, Alexandra, et al.
Publicado: (2016)

TET1 promotes fatty acid oxidation and inhibits NAFLD progression by hydroxymethylation of PPARα promoter
por: Wang, Jingjie, et al.
Publicado: (2020)

Chaetomorpha linum polysaccharides alleviate NAFLD in mice by enhancing the PPARα/CPT-1/MCAD signaling
por: Chu, Xueru, et al.
Publicado: (2022)

Novel Selective PPARα Modulator Pemafibrate for Dyslipidemia, Nonalcoholic Fatty Liver Disease (NAFLD), and Atherosclerosis †
por: Yamashita, Shizuya, et al.
Publicado: (2023)

Emergent Properties of the HNF4α-PPARγ Network May Drive Consequent Phenotypic Plasticity in NAFLD
por: Sahoo, Sarthak, et al.
Publicado: (2020)

The association of dietary inflammatory index (DII) and central obesity with non-alcoholic fatty liver disease (NAFLD) in people with diabetes (T2DM)
por: Soltanieh, Samira, et al.
Publicado: (2023)

PGC-1α Protects against Hepatic Ischemia Reperfusion Injury by Activating PPARα and PPARγ and Regulating ROS Production
por: Wang, Chaoqun, et al.
Publicado: (2021)

Identification of a potent NAFLD drug candidate for controlling T2DM-mediated inflammation and secondary damage in vitro and in vivo
por: Samsuzzaman, Md, et al.
Publicado: (2022)

Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs
por: Mukherjee, Anirban Goutam, et al.
Publicado: (2022)

Expression of TNF-α and IL-1β in Peripheral Blood of Patients with T2DM Retinopathy
por: Qian, Jin, et al.
Publicado: (2022)

PPARα Deficiency in Inflammatory Cells Suppresses Tumor Growth
por: Kaipainen, Arja, et al.
Publicado: (2007)

PPARα and PPARβ/δ are negatively correlated with proinflammatory markers in leukocytes of an obese pediatric population
por: Vargas-Sánchez, Karina, et al.
Publicado: (2020)

A Novel Role of Globular Adiponectin in Treatment with HFD/STZ Induced T2DM Combined with NAFLD Rats
por: Ma, Hong, et al.
Publicado: (2014)

The Hepatoprotection by Oleanolic Acid Preconditioning: Focusing on PPARα Activation
por: Wang, Wenwen, et al.
Publicado: (2018)

HIV-1 viral protein R (Vpr) induces fatty liver in mice via LXRα and PPARα dysregulation: implications for HIV-specific pathogenesis of NAFLD
por: Agarwal, Neeti, et al.
Publicado: (2017)

Metabolomics of the interaction between PPAR-α and age in the PPAR-α-null mouse
por: Atherton, Helen J, et al.
Publicado: (2009)

MDG-1, a Potential Regulator of PPARα and PPARγ, Ameliorates Dyslipidemia in Mice
por: Wang, Xu, et al.
Publicado: (2017)

The Role of Lipid Sensing Nuclear Receptors (PPARs and LXR) and Metabolic Lipases in Obesity, Diabetes and NAFLD
por: Dixon, Emmanuel D., et al.
Publicado: (2021)

Extracellular Vesicles as Inflammatory Drivers in NAFLD
por: Srinivas, Akshatha N., et al.
Publicado: (2021)

Is the rs1801282 (G/C) Polymorphism of PPAR - Gamma Gene Associated with T2DM in Iraqi People?
por: Al-Naemi, Amjad Hazim, et al.
Publicado: (2018)

Mechanisms Underlying the Functional Cooperation Between PPARα and GRα to Attenuate Inflammatory Responses
por: Bougarne, Nadia, et al.
Publicado: (2019)

Glucagon is associated with NAFLD inflammatory progression in type 2 diabetes, not with NAFLD fibrotic progression
por: Wang, Yuying, et al.
Publicado: (2021)

PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists
por: Silswal, Neerupma, et al.
Publicado: (2012)

An Ideal PPAR Response Element Bound to and Activated by PPARα
por: Tzeng, John, et al.
Publicado: (2015)

Insights from qualitative research on NAFLD awareness with a cohort of T2DM patients: time to go public with insulin resistance?
por: Alemany-Pagès, Mireia, et al.
Publicado: (2020)

PPARα and Effects of TCE
por: Klaunig, James E., et al.
Publicado: (2007)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

Deciphering the role of aberrant DNA methylation in NAFLD and NASH()
por: Vachher, Meenakshi, et al.
Publicado: (2022)

Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease
por: Jarmakiewicz-Czaja, Sara, et al.
Publicado: (2022)

PPAR-α Contributes to the Anti-Inflammatory Activity of Verbascoside in a Model of Inflammatory Bowel Disease in Mice
por: Esposito, Emanuela, et al.
Publicado: (2010)

The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)
por: Tanase, Daniela Maria, et al.
Publicado: (2020)

N-3 PUFA Supplementation Triggers PPAR-α Activation and PPAR-α/NF-κB Interaction: Anti-Inflammatory Implications in Liver Ischemia-Reperfusion Injury
por: Zúñiga, Jessica, et al.
Publicado: (2011)

The Synergistic Protective Effect of γ-Oryzanol (OZ) and N-Acetylcysteine (NAC) against Experimentally Induced NAFLD in Rats Entails Hypoglycemic, Antioxidant, and PPARα Stimulatory Effects
por: Alwadani, Ashwag H., et al.
Publicado: (2022)

Beta vulgaris L. (Beetroot) Methanolic Extract Prevents Hepatic Steatosis and Liver Damage in T2DM Rats by Hypoglycemic, Insulin-Sensitizing, Antioxidant Effects, and Upregulation of PPARα
por: Al-Harbi, Laila Naif, et al.
Publicado: (2021)

The PPARα and PPARγ Epigenetic Landscape in Cancer and Immune and Metabolic Disorders
por: Porcuna, Jesús, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t04usmbvb15lrr5ul8ald2rad3